Health Care Affordability Event
Presenter · April 24, 2026
A presenter announced a pharmaceutical pricing pledge by major drug companies and said the FDA approved Regeneron's gene therapy Otarminy for a rare form of deafness, introducing 2-year-old Travis Smith as an example of the condition.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.